Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Restructuring Costs: 2022-2024

Historic Restructuring Costs for Akebia Therapeutics (AKBA) over the last 3 years, with Dec 2024 value amounting to $58,000.

  • Akebia Therapeutics' Restructuring Costs fell 45.28% to $58,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $239,000, marking a year-over-year decrease of 98.51%. This contributed to the annual value of $58,000 for FY2024, which is 67.96% down from last year.
  • Latest data reveals that Akebia Therapeutics reported Restructuring Costs of $58,000 as of FY2024, which was down 67.96% from $181,000 recorded in FY2023.
  • In the past 5 years, Akebia Therapeutics' Restructuring Costs ranged from a high of $15.9 million in FY2022 and a low of $58,000 during FY2024.
  • In the last 3 years, Akebia Therapeutics' Restructuring Costs had a median value of $181,000 in 2023 and averaged $5.4 million.
  • Data for Akebia Therapeutics' Restructuring Costs shows a maximum YoY plummeted of 98.86% (in 2023) over the last 5 years.
  • Over the past 3 years, Akebia Therapeutics' Restructuring Costs (Yearly) stood at $15.9 million in 2022, then plummeted by 98.86% to $181,000 in 2023, then tumbled by 67.96% to $58,000 in 2024.